Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74,418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant.
Zhang C, Wang XQ, Zhang RL, Liu F, Wang Y, Yan ZL, Song YP, Yang T, Li P, Wang Z, Ma YY, Gao L, Liu Y, Gao L, Kong PY, Liu J, Tan X, Zhong JF, Chen YQ, Liang AB, Ren JH, Li ZY, Cao J, Gao QL, Zhou J, Gao Y, Zhang D, Fan FY, Han MZ, Gale RP, Zhang X. Zhang C, et al. Among authors: zhang rl, zhang d, zhang x. Leukemia. 2021 Jun;35(6):1563-1570. doi: 10.1038/s41375-020-01056-6. Epub 2020 Oct 19. Leukemia. 2021. PMID: 33077866 Free PMC article.
Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation.
Tan X, Wang XQ, Zhang C, Zhao XL, Yao H, Chen G, Ma YY, Wen Q, Gao L, Gao L, Kong PY, Shen Y, Zhang X, Lou SF. Tan X, et al. Among authors: zhang c, zhang x. Curr Med Sci. 2023 Aug;43(4):733-740. doi: 10.1007/s11596-023-2746-1. Epub 2023 Jun 17. Curr Med Sci. 2023. PMID: 37330456
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial.
Huang R, Chen T, Wang S, Wang J, Su Y, Liu J, Zhang Y, Ma X, Wen Q, Kong P, Zhang C, Gao L, Zhong JF, Gao L, Zhang X. Huang R, et al. Among authors: zhang c, zhang x, zhang y. JAMA Oncol. 2024 Feb 1;10(2):220-226. doi: 10.1001/jamaoncol.2023.5757. JAMA Oncol. 2024. PMID: 38153755 Free PMC article. Clinical Trial.
Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme.
Wang L, Kong P, Zhang C, Gao L, Zhu L, Liu J, Gao S, Chen T, Liu H, Yao H, Liu Y, Feng Y, Zhao L, Li Y, Gao L, Zhang X. Wang L, et al. Among authors: zhang c, zhang x. Ann Hematol. 2023 Jun;102(6):1569-1579. doi: 10.1007/s00277-023-05220-7. Epub 2023 Apr 25. Ann Hematol. 2023. PMID: 37097455 Free PMC article.
Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia.
Xiang X, Li F, Zhou S, Zeng Y, Deng X, Zhang H, Li J, Liu H, Rao J, Gao L, Zhang C, Wen Q, Gao L, Zhang X. Xiang X, et al. Among authors: zhang c, zhang h, zhang x. PPAR Res. 2023 Jun 26;2023:8456833. doi: 10.1155/2023/8456833. eCollection 2023. PPAR Res. 2023. PMID: 37404899 Free PMC article.
74,418 results
You have reached the last available page of results. Please see the User Guide for more information.